MAGE revisited: Evaluation of glucose variability with once daily glargine vs NPH insulin in type 2 diabetes

被引：0
|
作者：
Silvani, G. [1 ]
Acquati, S. [1 ]
Manini, R. [1 ]
Ragazzini, C. [1 ]
Taroni, S. [1 ]
Donadio, F. [1 ]
Buci, L. [1 ]
Gagliardi, L. [1 ]
Tartaglia, A. [1 ]
Nizzoli, M. [1 ]
机构：
[1] GB Morgagni L Pierantoni Hosp, Forli, Italy
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
978
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial
    Douglas Eugenio Barbieri
    Ran Duan
    Jorge Gross
    Bruno Linetzky
    Janaina Martins De Lana
    Arturo Rojas
    Georgina Sposetti
    Oded Stempa
    Angel Rodriguez
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [42] Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens
    Rosenstock, J
    Park, G
    Zimmerman, J
    DIABETES CARE, 2000, 23 (08) : 1137 - 1142
  • [43] Comparison of insulin Glargine (HOE901) vs NPH insulin during 1 year of insulin combination therapy in type 2 diabetes
    Yki-Jarvinen, H
    Dressler, A
    Zieman, M
    DIABETES, 2000, 49 : A130 - A131
  • [44] Less weight gain with insulin deternir once daily compared to NPH insulin particularly for obese subjects with type 2 diabetes
    Philis-Tsimikas, Athena
    Koenen, Christoph
    Pedersen, Claus B.
    Thorsteinsson, Birger
    DIABETES, 2007, 56 : A130 - A130
  • [45] Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus
    Yoshihara, T
    Kumashiro, N
    Kanazawa, Y
    Mita, T
    Sakurai, Y
    Kawai, J
    Abe, M
    Motojima, K
    Hara, K
    Yamazaki, Y
    Kanazawa, A
    Miwa, S
    Sato, F
    Kanno, R
    Shimizu, T
    Sakai, K
    Uchino, H
    Watada, H
    Tanaka, Y
    Kawamori, R
    Hirose, T
    ENDOCRINE JOURNAL, 2006, 53 (01) : 67 - 72
  • [46] Once daily dosing with insulin detemir offers advantages compared to NPH insulin in subjects with type 1 diabetes
    Russel-Jones, D
    Bolinder, J
    Simpson, R
    Stades, A
    Stender, A
    Hylleberg, B
    Draeger, E
    DIABETES, 2003, 52 : A132 - A132
  • [47] Insulin Glargine (GLAR) and NPH Insulin (NPH) in Real Life in Russia in Patients with Type 2 Diabetes (T2D)
    Shestakova, Marina V.
    Glinkina, Irina V.
    DIABETES, 2009, 58 : A530 - A530
  • [48] Comparison of once daily glargine insulin with twice daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery
    Yeldandi, RR
    Lurie, A
    Baldwin, J
    Baldwin, D
    DIABETES, 2005, 54 : A126 - A126
  • [49] Effect of insulin glargine and NPH on quality of life in patients with type 2 diabetes mellitus
    Gupta, K.
    Gupta, U.
    Singh, N.
    VALUE IN HEALTH, 2006, 9 (06) : A237 - A237
  • [50] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    Heise, T
    Nosek, L
    Ronn, BB
    Endahl, L
    Heinemann, L
    Kapitza, C
    Draeger, E
    DIABETES, 2004, 53 (06) : 1614 - 1620
12345